Kalaris Therapeutics, Inc. - KLRS

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 18
Latest filed: Apr 10, 2026
Form Count
8-K 7
4 7
SCHEDULE 13D/A 2
144 1
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Apr 10, 2026 8-K Apr 08, 2026 0001193125-26-151215 View
Mar 23, 2026 4 Mar 19, 2026 0001193125-26-119707 View
Mar 20, 2026 4 Mar 19, 2026 0001193125-26-117616 View
Mar 20, 2026 4 Mar 19, 2026 0001193125-26-117617 View
Mar 20, 2026 4 Mar 19, 2026 0001193125-26-117618 View
Mar 20, 2026 144 0001950047-26-002859 View
Mar 17, 2026 8-K Mar 17, 2026 0001193125-26-109437 View
Mar 09, 2026 8-K Mar 09, 2026 0001193125-26-097548 View
Feb 17, 2026 SCHEDULE 13G 0001493215-26-000038 View
Feb 17, 2026 SCHEDULE 13D/A 0001699737-26-000007 View
Feb 17, 2026 4 Dec 18, 2025 0001231919-26-000166 View
Dec 22, 2025 SCHEDULE 13D/A 0001699737-25-000032 View
Dec 22, 2025 4 Dec 22, 2025 0001231919-25-000652 View
Dec 18, 2025 8-K Dec 17, 2025 0001193125-25-323706 View
Dec 17, 2025 8-K Dec 17, 2025 0001193125-25-322950 View
Nov 12, 2025 8-K Nov 12, 2025 0001193125-25-276060 View
Nov 03, 2025 8-K Oct 28, 2025 0001193125-25-261697 View
Nov 03, 2025 4 Nov 03, 2025 0001193125-25-262831 View